Unusual treatment of a gastric marginal zone B-cell lymphoma of MALT type

Zeitschrift fur Gastroenterologie

Volumn 45, Issue 5, 2007, Pages 383-386

  Fischbach, Wolfgang ^a   Keller, R ^a   Englert, D ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Gastric; Laparoscopic resection; MALT lymphoma; Therapy

Indexed keywords

ANTINEOPLASTIC AGENT; RITUXIMAB;

ADULT; ARTICLE; B CELL LYMPHOMA; CANCER REGRESSION; CANCER STAGING; CASE REPORT; ENDOSCOPIC SURGERY; ERADICATION THERAPY; GASTRECTOMY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PATIENT ABANDONMENT; STOMACH FUNDUS; STOMACH LYMPHOMA; TREATMENT INDICATION; TUMOR BLEEDING; LAPAROSCOPY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR; TREATMENT OUTCOME;

HUMANS; LAPAROSCOPY; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MALE; MIDDLE AGED; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 34447249062     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-927272     Document Type: Article

References (16)

1. Fischbach W. Gastrointestinale Lymphome. Z Gastroenterol 2004; 42: 1067-1072
2. Jaffe ES, Harris NL, Stein H et al. World Health Organization and Classification of Tumours: Pathology and Genetics: Tumours of Haematopoetic and Lymphoid Tissues. Lyon: IARC Press, 2002
3. Cogliatti SB, Schmid U, Schumacher U et al. Primary B-cell gastric lymphoma: a clinico-pathological study of 145 patients. Gastroenterology 1991; 101: 1159-1170
4. Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue. Factors relevant to prognosis. Gastroenterology 1992; 102: 1628-1638
5. Fischbach W. Primary gastric lymphoma of MALT: Considerations of pathogenesis, diagnosis and therapy. Can J Gastroenterol 2000; 14: 44D-50D
6. Fischbach W, Goebeler-Kolve ME, Dragosics B et al. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication: experience from a large prospective series. Gut 2004; 53: 34-37
7. Wündisch T, Thiede C, Morgner A et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol 2005; 23: 1-7
8. Fischbach W, Goebeler-Kolve M, Starostik P et al. Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori. Lancet 2002; 360: 547-548
9. Fischbach W, Goebeler-Kolve M, Ruskone-Fourmestraux A et al. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be safely managed by a watch-and-wait strategy. Experience from a large international series. Gastroenterology 2005; 128 (Suppl 2): A-289
10. Koch P, del Valle F, Berdel W et al. Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma. Results of the prospective German multicenter study GIT NHL 01/92. J Clin Oncol 2001; 19: 3874-3883
11. Fischbach W, Dragosics B, Kolve-Goebeler ME et al. Primary gastric B-cell lymphoma: results of a prospective multicenter study. Gastroenterology 2000; 119: 1191-1202
12. Hammel P, Haioun C, Chaumette M et al. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol 1995; 13: 2524-2529
13. Jaeger G, Neumeister P, Brezinschek R et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue-type with cladribine: A phase II study. J Clin Oncol 2002; 20: 3872-3877
14. Wöhrer S, Drach J, Hejna M et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP). Ann Oncol 2003; 14: 1758-1761
15. Martinell G, Lazlo D, Ferreri A et al. Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J Clin Oncol 2005; 23: 1979-1783
16. Coiffier B, Lepage E, Briere J et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma. N Engl J Med 2002; 346: 235-242